Loss of spiral ganglion cells as primary manifestation of aminoglycoside ototoxicity

Michihiko Sone, Patricia A. Schachern, Michael M. Paparella

Research output: Contribution to journalArticlepeer-review

50 Scopus citations


Although pulmonary infections caused by Pseudomonas aeruginosa can hardly be eradicated in patients with cystic fibrosis (CF, the most common genetic disease among Caucasians), these patients are mainly treated with intravenous and nebulized tobramycin. Long-term treatment with tobramycin, however, may induce ototoxic effects. We assessed the clinical histories and postmortem temporal bones of six patients with CF for signs of this ototoxicity. Four bones showed typical manifestations of ototoxicity induced by aminoglycosides (AGs): loss of hair cells in the lower turns, and degeneration of ganglion cells. Six bones revealed no loss or scattered loss of hair cells, however, degeneration of the spiral ganglion cells was observed. This suggests that degeneration of the spiral ganglion may occur as a primary manifestation in some cases of ototoxicity due to aminoglycosides. Recent reports have shown that trophic factors (neurotrophins and acidic fibroblast growth factor) interacting with hair cells and the spiral ganglion protect the inner ear from damage. It may be that disturbances in supply of such trophic factors caused degeneration of ganglion cells without loss of hair cells in the cases we studied.

Original languageEnglish (US)
Pages (from-to)217-223
Number of pages7
JournalHearing Research
Issue number1-2
StatePublished - Jan 1 1998


  • Cystic fibrosis
  • Degeneration
  • Ototoxicity
  • Spiral ganglion cell
  • Tobramycin

Fingerprint Dive into the research topics of 'Loss of spiral ganglion cells as primary manifestation of aminoglycoside ototoxicity'. Together they form a unique fingerprint.

Cite this